Table I.
Baseline characteristics of clinicopathological factors.
| ADAMTS5 | |||
|---|---|---|---|
| Characteristic | Low group (n=72) | High group (n=71) | P-value |
| Gender | 0.1533 | ||
| Male, n (%) | 52 (73.24) | 43 (60.56) | |
| Female, n (%) | 19 (26.76) | 28 (39.44) | |
| Histologic type | 1.000 | ||
| tub1-tub2, n (%) | 69 (95.83) | 68 (95.77) | |
| por-sig, n (%) | 3 (4.17) | 3 (4.23) | |
| Lymphatic invasion | 0.0214 | ||
| Positive, n (%) | 47 (65.28) | 59 (83.10) | |
| Negative, n (%) | 25 (34.72) | 12 (16.90) | |
| Venous invasion | 0.7348 | ||
| Positive, n (%) | 41 (56.94) | 43 (60.56) | |
| Negative, n (%) | 31 (43.06) | 28 (39.44) | |
| Depth of tumor invasion | 0.4205 | ||
| T0/T1/T2 | 6/5/7 | 2/1/10 | |
| T3 | 25 | 28 | |
| T4a | 22 | 25 | |
| T4b | 7 | 3 | |
| T0-2/T3-4 | 18/54 | 13/56 | |
| Lymph node metastasis | 0.0289 | ||
| Positive, n (%) | 25 (34.72) | 38 (53.52) | |
| Negative, n (%) | 47 (65.28) | 33 (46.48) | |
| UICC stage | 0.0896 | ||
| 0/I/II/III/IV | 5/12/29/17/9 | 2/9/18/27/15 | |
| Distant metastasis | 0.1675 | ||
| Positive | 9 | 15 | |
| Negative | 63 | 56 | |
UICC, the union internationale contre le cancer.